1. Home
  2. ACLX vs LBTYK Comparison

ACLX vs LBTYK Comparison

Compare ACLX & LBTYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • LBTYK
  • Stock Information
  • Founded
  • ACLX 2015
  • LBTYK 2004
  • Country
  • ACLX United States
  • LBTYK Bermuda
  • Employees
  • ACLX N/A
  • LBTYK N/A
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • LBTYK Cable & Other Pay Television Services
  • Sector
  • ACLX Health Care
  • LBTYK Telecommunications
  • Exchange
  • ACLX Nasdaq
  • LBTYK Nasdaq
  • Market Cap
  • ACLX 3.5B
  • LBTYK 3.5B
  • IPO Year
  • ACLX 2022
  • LBTYK N/A
  • Fundamental
  • Price
  • ACLX $67.16
  • LBTYK $10.21
  • Analyst Decision
  • ACLX Strong Buy
  • LBTYK
  • Analyst Count
  • ACLX 14
  • LBTYK 0
  • Target Price
  • ACLX $111.42
  • LBTYK N/A
  • AVG Volume (30 Days)
  • ACLX 567.9K
  • LBTYK 1.3M
  • Earning Date
  • ACLX 08-07-2025
  • LBTYK 01-01-0001
  • Dividend Yield
  • ACLX N/A
  • LBTYK N/A
  • EPS Growth
  • ACLX N/A
  • LBTYK N/A
  • EPS
  • ACLX N/A
  • LBTYK N/A
  • Revenue
  • ACLX $76,809,000.00
  • LBTYK $4,421,800,000.00
  • Revenue This Year
  • ACLX N/A
  • LBTYK $8.29
  • Revenue Next Year
  • ACLX $112.68
  • LBTYK $0.74
  • P/E Ratio
  • ACLX N/A
  • LBTYK N/A
  • Revenue Growth
  • ACLX N/A
  • LBTYK 32.44
  • 52 Week Low
  • ACLX $47.86
  • LBTYK $9.21
  • 52 Week High
  • ACLX $107.37
  • LBTYK $22.14
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 57.86
  • LBTYK 51.75
  • Support Level
  • ACLX $63.13
  • LBTYK $10.13
  • Resistance Level
  • ACLX $67.83
  • LBTYK $10.62
  • Average True Range (ATR)
  • ACLX 2.49
  • LBTYK 0.29
  • MACD
  • ACLX 0.09
  • LBTYK 0.03
  • Stochastic Oscillator
  • ACLX 80.46
  • LBTYK 53.93

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About LBTYK Liberty Global Ltd. Class C

Liberty Global is a holding company with interests in several telecom companies in the UK, the Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies, and has pursued a strategy since 2016 to merge or partner with mobile-network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

Share on Social Networks: